Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
Completed
- Conditions
- Gastric UlcerDuodenal Ulcer
- Registration Number
- NCT02423187
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
To investigate the safety and efficacy of long-term combination therapy with rabeprazole and low-dose aspirin.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1568
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse drug reactions 52 weeks
- Secondary Outcome Measures
Name Time Method Recurrence rate of peptic ulcer 52 weeks